Improving access to HCC care globally & the importance of HIV co-infection: Research advancing the field [Hosted by NCI]
The next webinar in the "Moving from Hepatitis Discovery to Elimination: NIH Research Advancing Hepatitis Elimination" series will be hosted by the National Cancer Institute (NCI) and will feature presentations from NCI-supported researchers on improving access to hepatocellular cancer (HCC) diagnosis, treatment, and care. Speakers will discuss liver cancer projects in Taiwan, Vietnam, and Uganda. In addition, speakers will highlight recent developments in our understanding of the relationship between HCC and HIV infection.
Agenda
Welcome | John Ward, Coalition for Global Hepatitis Elimination
Betsy Read-Connole, NCI, NIH
Jo Ann Rinaudo, NCI, NIH
Opening remarks from Dr. Doug Lowy, Acting Director, NCI, NIH
Dr. Jill Koshiol, National Cancer Institute| Circulating Immunologic Markers and Hepatocellular Carcinoma
Dr. Doan Dao, Center of Excellence for Liver Disease in Vietnam, Johns Hopkins School of Medicine| Joint Actions for Liver Cancer Control in Vietnam
Dr. Gregory Kirk, Johns Hopkins School of Medicine| HIV and Hepatocellular Carcinoma in Africa: The H2A Consortium
Panel Discussion
- Dr. Ponsiano Ocama, Makerere University College of Health Sciences and Kiruddu National Referral Hospital
Email globalhep [at] taskforce.org with any questions or concerns.
